Health

Thyrocare Launches India’s First Pregnancy Kit Backed by a Lab Test; Yami Gautam Named Brand Ambassador
Thyrocare Launches India’s First Pregnancy Kit Backed by a Lab Test; Yami Gautam Named Brand Ambassador

Mumbai (Maharashtra) [India], November 3: Thyrocare Technologies Limited (“Thyrocare”; NSE: THYROCARE, BSE: 539871), one of India’s largest diagnostics companies, today entered the pregnancy testing segment with the launch of the Thyrocare Pregnancy Kit, the first pregnancy kit in India to come bundled with a quantitative laboratory confirmation test. The company has also appointed actor Yami Gautam as brand ambassador for the kit.

The kit contains a rapid at-home pregnancy test and a voucher for a Thyrocare Beta hCG laboratory test at half its regular price, with home sample collection included. A home test reads a hormone level as a line on a strip; the Beta hCG test measures that hormone precisely in an accredited laboratory. Together they give a woman an immediate answer and, when she wants it, a number to confirm it.

Thyrocare operates 46 laboratories and 11,310 collection points across 607 districts, processing 1 lakh+ samples a day. Its laboratories are NABL-accredited. That infrastructure is what makes the pairing possible: a woman who takes the home test can book the confirmatory Beta hCG through the Thyrocare website by scanning a QR code inserted in the packaging and have a sample collected at home, usually within a few hours.

The launch extends Thyrocare’s consumer-facing diagnostics business into a category that reaches Indian households directly. More than 150 million pregnancy tests are sold in India each year, almost all of them read and acted on at home without any laboratory follow-up.

Yami Gautam brings to the association a public voice built on doing the research rather than taking the first answer, which is the idea the kit is built on. A working mother who has spoken often about nutrition and family wellness, she is the brand ambassador for the Thyrocare Pregnancy Kit across its launch campaign.

“When it comes to a pregnancy result, every woman deserves clarity and reassurance. The Thyrocare Pregnancy Kit gives a quick answer at home and a lab to back it – a reassuring combination for such an important moment,” said Yami Gautam Dhar.

“Every year, millions of Indian women take a pregnancy test at home and are left with a line on a strip and no way to confirm it. We have spent two decades building the laboratory network that answers that question properly. Putting the two in one box is the obvious next step, and it is where consumer healthcare is going: a quick answer at home, with clinical confirmation one step away,” said Rahul Guha, MD and CEO of Thyrocare.

The Thyrocare Pregnancy Kit is available at leading pharmacies, e-commerce and q-commerce platforms at an MRP of Rs. 60. Each pack contains an at-home rapid pregnancy test kit with a test sensitivity of 25 mIU/mL, a dropper and a coupon code to avail beta-HCG blood test at home. The bundled Beta hCG laboratory test is offered at Rs. 399, half its regular price of Rs. 800, with home sample collection included. The voucher is valid for 6 months from purchase.

If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.

Why Women Are Anaemic at 3x the Rate of Men–the biology nobody talks about! Explains Livlong 365
Why Women Are Anaemic at 3x the Rate of Men–the biology nobody talks about! Explains Livlong 365
Fredna Vet Diagnostics Uncovers Widespread Bone Tumour in Dog Through Advanced CT Imaging
Fredna Vet Diagnostics Uncovers Widespread Bone Tumour in Dog Through Advanced CT Imaging
Child Not Improving in Therapy? Why a Full Child Psychological Assessment Should Come First, as Indian-Origin Parents Abroad Seek Online Help
Child Not Improving in Therapy? Why a Full Child Psychological Assessment Should Come First, as Indian-Origin Parents Abroad Seek Online Help

Business

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin
From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

All-stock 100% acquisition | ₹354.52 crore | Board also approves ESOS 2026

New Delhi [India], November 6: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012), a vertically integrated cashew processing company with farm-gate sourcing across key producing origins and a growing consumer brand, ‘Royal Mewa’, has announced that its Board of Directors, has approved the acquisition of a 100% equity stake in Pacific Global FZCO, Dubai (UAE) (“Pacific Global”), an origin-based cashew processing platform with an installed capacity of 60,000 MT of raw cashew nuts (RCN) per annum in Côte d’Ivoire, for a total consideration of ₹354.52 crore, to be discharged entirely through a share swap.

From Local to Global: The acquisition marks a strategic shift in Pajson Agro’s growth trajectory, from an India-based processor to an origin-integrated, global cashew platform. Côte d’Ivoire is the world’s largest producer of raw cashew nuts, and a processing footprint at source places the Company at the heart of global supply, strengthening control over raw-material access, quality and cost. Processing at origin while serving multiple international markets also provides a natural hedge across sourcing, geographies and end-markets.

Scale for India and the World: On completion of the acquisition, the Company’s processing capacity will scale to a combined 1,13,000 MT, comprising its existing 18,000 MT in India, the 35,000 MT greenfield facility being set up at Vizianagaram, Andhra Pradesh, and 60,000 MT in Côte d’Ivoire. This builds scale for India and global demand alike, in line with the Company’s ambition to lead the cashew value chain.

Established Platform, Global Customers: Pacific Global, through its wholly owned subsidiaries, procures RCN, manages inventory and processes it into cashew kernels, which are sold to international customers across the US, Europe, the Middle East and China. For January–August 2026, it reported a consolidated turnover of AED 40.32 million (₹104.18 crore), with a consolidated net worth of AED 135.92 million (₹351.20 crore) as on August 31, 2026.

Capital-Efficient, Long-Term Alignment: The consideration will be settled through a preferential issue of up to 1,20,58,397 equity shares of face value ₹10 each, at an issue price of ₹294 per share, to the shareholders of Pacific Global, in accordance with Chapter V of the SEBI (ICDR) Regulations, 2018. The all-stock structure involves no cash outflow, values the acquisition at approximately 1.0x Pacific Global’s net worth, and aligns the incoming shareholders with the Company’s long-term value creation. The transaction is subject to shareholder and other applicable approvals, and is expected to be completed within approximately 2–3 months thereafter.

Investing in People through ESOS 2026: The Board also approved the Pajson Agro Employee Stock Option Scheme 2026 (“ESOS 2026”), with a pool of up to 11,90,480 options, each exercisable into one equity share. Administered by the Nomination and Remuneration Committee and extendable to eligible employees of group companies, including subsidiaries, the scheme is designed to attract, reward and retain talent and to give employees a direct stake in the Company’s growth. The Board further approved an increase in the authorised share capital from ₹25 crore to ₹40 crore.

Commenting on the update, Mr. Aayush Jain, Promoter, Chairman & Managing Director, said: “This acquisition is a defining milestone in Pajson Agro’s journey. It takes us from a local processor to a company with a global strategic footprint, right at the origin. Côte d’Ivoire is the world’s largest producer of raw cashew nuts, and 60,000 MT of processing capacity there places us at the centre of global supply.

With combined capacity scaling to 1,13,000 MT, we are building scale not just for India but for the world, and we are clearly targeting a leadership position in the cashew industry. Processing at origin and serving customers across multiple markets also gives us a clear natural hedge. The opportunities ahead are significant, and through ESOS 2026 our people will share in the value they help create.”

Mr. Pulkit Jain, Promoter & Non-Executive Director, Pajson Agro India Limited, and Majority Shareholder, Pacific Global FZCO, added: “Pacific Global has established an origin-based processing operation in Côte d’Ivoire with access to international customers, and bringing it into Pajson Agro unites sourcing, processing and global sales under one listed company. As the majority shareholder of Pacific Global, I have chosen to receive the entire consideration in Pajson Agro shares, not cash. This reflects my confidence in the Company’s long-term prospects and keeps my interests aligned with those of every Pajson Agro shareholder.”

About Pajson Agro India Limited

Pajson Agro India Limited (“Pajson Agro” or “the Company”) is a vertically integrated cashew processing company that converts raw cashew nuts (RCN) into high-quality, market-ready kernels for institutional and retail customers. Backed by the Pajson Group’s sourcing presence across key producing origins in West Africa, the Company procures raw nuts through long-standing farm-gate relationships.

The Company operates a technology-driven processing facility at Visakhapatnam, Andhra Pradesh, with an installed capacity of 18,000 MTPA, and is setting up a greenfield facility at Vizianagaram, Andhra Pradesh. It serves leading confectionery and snack manufacturers along with a network of over 178 distributors across 20+ states, and markets premium dry fruits under its consumer brand ‘Royal Mewa’.

Website: https://pajsonagro.com/

For FY26, the company reported Total Income of ₹256.92 crore, EBITDA of ₹37.82 crore, and PAT of ₹24.78 crore.

The company was listed on BSE SME in December 2025.

Disclaimer: Certain statements in this document that are not historical facts are forward looking statements. Such forward looking statements are subject to certain risks and uncertainties like government actions, local, political or economic developments, technological risks, and many other factors that could cause actual results to differ materially from those contemplated by the relevant forward-looking statements. The Company will not be in any way responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27
Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27
Patil Automation Marks a Strong First Half of FY27; Consolidated Revenue Up 37% YoY, Net Profit Up 48%
Patil Automation Marks a Strong First Half of FY27; Consolidated Revenue Up 37% YoY, Net Profit Up 48%
Bright Outdoor Media Limited Makes Its Debut On The Main Boards Of BSE And NSE, Marking A New Chapter In Its Growth Journey
Bright Outdoor Media Limited Makes Its Debut On The Main Boards Of BSE And NSE, Marking A New Chapter In Its Growth Journey